Skip to main content Skip to section navigation Skip to footer
Back to AchieveLifeSciences.com
Achieve Life Sciences, Inc. Investor Relations
  • Investors
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Information

Press Releases

News & Events

News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
May 30, 2019 5:30am EDT

Achieve Announces Patent Granted in the U.S. for Novel Formulation of Cytisinicline

May 15, 2019 4:05pm EDT

Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update

May 07, 2019 5:30am EDT

Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019

Apr 24, 2019 5:30am EDT

Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation

Apr 03, 2019 5:30am EDT

Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019

Apr 02, 2019 5:30am EDT

Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation

Mar 18, 2019 5:30am EDT

Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019

Mar 14, 2019 4:05pm EDT

Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update

Mar 05, 2019 5:30am EST

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019

Feb 22, 2019 5:30am EST

Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting

  • Previous Pagearrow_back
  • Page 1…
  • …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2023 Achieve Life Sciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap